| Makale Türü |
|
||
| Dergi Adı | Eurasian Journal of Medicine | ||
| Dergi ISSN | 1308-8734 | ||
| Dergi Tarandığı Indeksler | ESCI | ||
| Makale Dili | İngilizce | Basım Tarihi | 10-2020 |
| Cilt / Sayı / Sayfa | 52 / 3 / 277–282 | DOI | 10.5152/eurasianjmed.2020.20033 |
| Makale Linki | https://www.eajm.org/en/role-of-endothelin-1-on-proliferation-and-migration-of-human-mcf-7-cells-133297 | ||
| Özet |
| Objective The aim of this study was to explore the role of endothelin 1 (ET-1) in human breast cancer proliferation and migration and antagonism of endothelin receptor A (ETAR) and endothelin receptor B (ETBR) by using the non-selective dual ETA/ETB receptor antagonist bosentan and determine its anti-proliferative, anti-metastatic, and apoptotic effects demonstrated by nuclear factor kappa B (NF-kB), vascular endothelial growth factor (VEGF), Caspase 3 and Caspase 9 expression on endothelin-induced proliferation of MCF-7 cell line in vitro. Materials and Methods A total of 8,000 cells were seeded into e-plates 24 hours after the cells were incubated with or without 10-4 M BOS (1 hour before ET-1 treatment); 10-7, 10-8, and 10-9 M ET-1 for 1–4 days. Results Whether ET-1 is present or not in the tumor area, bosentan exerts anti-proliferative effect on breast cancer. However, ET-1 and bosentan group showed … |
| Anahtar Kelimeler |
| Bosentan | Cancer | ET-1 | MCF-7 | Metastasis |
| Atıf Sayıları | |
| Web of Science | 8 |
| Scopus | 8 |
| Google Scholar | 10 |